


|


|
Topic
Top news source/blog that we're missing
Why do you recommend this news source?
|
||

WIKI ANALYSIS
|
DENTSPLY International Inc.(NASDAQ:XRAY) is the world's largest manufacturer of dental products, such as dental anesthetics and artificial teeth, by revenue ($1.8B in 2006).[1] DENTSPLY's sells its products to dentists, dental hygienists, dental schools, and laboratories. [2]
DENTSPLY International, Inc. engages in the design, development, manufacture, and marketing of dental consumables, dental laboratory products, and dental specialty products worldwide. Its dental consumable products include dental sundries, such as dental anesthetics, prophylaxis paste, dental sealants, impression materials, restorative materials, bone grafting materials, tooth whiteners, and topical fluoride; and small equipment products, including high and low speed handpieces, intraoral curing light systems, and ultrasonic scalers and polishers used in dental offices for treatment of patients. XRAY’s specialty dental products include endodontic instruments and materials, implants and related products, and orthodontic appliances and accessories. Its products are used for specific purposes within the dental office and laboratory settings.
The company markets its products primarily to dentists, dental hygienists, dental assistants, dental laboratories, and dental schools. It distributes its products through domestic and foreign distributors, dealers, and importers, as well as directly through sales staff.
With customers in 120 countries and 58% of its 2006 revenues originating outside of the U.S., X-Ray revenues are geographically diverse. The company's customers can be segmented into two groups -- those in developed countries and those in developing countries. Customers in developed countries require a wide variety of products, including those associated with higher end, cosmetic and restorative procedures, whereas demand in developing countries is limited to basic products like fillings and anesthetics. The company's management expects that continued growth of personal incomes in developing countries with rapidly developing economies, such as China and India, will lead to greater demand for its more advanced products.
Business Overview DENTSPLY was founded in 1983 and is headquartered in York, Pennsylvania. They operate in three main business segments:
In 2006, XRAY had revenue of $1.8B , a 5.6% increase over the $1.7B revenue in 2005. [7] In 2005, pre-tax operating income was significantly lower due to restructuring, impairment and other costs of $232.8 million. These costs were related to its injectable anesthetic business. In 2005, the company received results from a Food and Drug Administration’s (FDA’s) Pre-Approval Inspection of the company's pharmaceutical manufacturing facility outside of Chicago. From the analysis, XRAY concluded that the facilities ability to begin manufacturing injectable anesthetics would be would be delayed for several more years. Based on that analysis, the firm decided to outsource the manufacturing of the dental anesthetic products and stop the construction of the pharmaceutical manufacturing facility. Due to these actions, the company took a write down.[8]
International revenues accounted for 58% of the company's revenue, with US sales accounting for the remaining 42% of revenue.[10]
Trends and Forces
Market ShareXRAY has a leading market share in dental supplies and equipment across North America, Europe, and Asia. Below is market share by revenue in its three main regions. It holds the strongest position in the North American dental supplies market, with nearly a 1/4th share.
CompetitionWhile XRAY has a strong market position, it faces tough competition from divisions of many companies, including:
| Company | Total Sales | Net Income |
|---|---|---|
| DENTSPLY International | $1,810 M [18] | $224 M [19] |
| Danaher (DHR) | $9,596 M [20] | $1,131 M [21] |
| Align Technology (ALGN) | $206 M [22] | ($35) M [23] |
References



| ||||||
